Observational studyBMC neurology2021

Clinical characteristics of middle-aged and older patients with MS treated with interferon beta-1b: post-hoc analysis of a 2-year, prospective, international, observational study.

Francesco Patti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.